Thousands enrolled in supraflex stent registry for coronary artery disease

NCT ID NCT03443999

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This registry is tracking 10,000 patients with coronary artery disease who receive the Supraflex sirolimus-eluting stent during routine care. The goal is to see how well the stent works in everyday practice, measuring outcomes like heart-related death, heart attacks, and the need for repeat procedures. Participants will be followed for up to five years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Supraflex Family Sirolimus-eluting Coronary Stent System
What this could lead to
If successful, this could confirm that the Supraflex stent is safe and effective for routine use in a wide range of patients with blocked heart arteries.
What could go wrong
This is an observational registry, not a randomized trial, so results may be influenced by patient selection. Stent procedures carry risks like blood clots or re-narrowing of arteries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Albert Schweitzer Ziekenhuis

    RECRUITING

    Dordrecht, South Holland, Post bus 444 3300 AK, Netherlands

  • Amphia Ziekenhuis

    RECRUITING

    Breda, North Brabant, 4818 CK Breda, Netherlands

  • Catharina Ziekenhuis

    RECRUITING

    Eindhoven, North Brabant, 5623 EJ, Netherlands

  • Maasstad Ziekenhuis

    RECRUITING

    Rotterdam, South Holland, 3079 DZ, Netherlands

  • Medical Center Leeuwarden

    RECRUITING

    Leeuwarden, Provincie Friesland, 8934 AD, Netherlands

  • Tergooi Ziekenhuis

    RECRUITING

    Blaricum, North Holland, 1261 AN, Netherlands

  • ZorgSaam Hospital

    RECRUITING

    Terneuzen, Zeeuws- Vlaanderen, 4535 PA, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.